Explore Fear & Greed indicators derived from media coverage across economies and asset classes.
If you are interested in our products, want to see one of our data samples, please leave your email below.
AI-derived sentiment indicator based on analysis of public internet content using artificial intelligence agents discussing JPMorgan earnings and banking conditions.
JP Morgan Chase strengthens its stake in Viridien. JPMorgan profit beats estimates on record trading haul and strong dealmaking.
JPMorgan's profits rose by 13% in the first quarter, with net profit increasing by the same percentage and revenue by 10%. CEO Dimon warned of an 'increasingly complex set of risks' ahead, including the impact of war on the economic outlook.
JPMorgan returns to 'overweight' stance on emerging market FX, indicating the contours of the end game in the Middle East war are emerging.
JPMorgan beats expectations in the first quarter of 2026, with profits rising 13% as Dimon warns of an 'increasingly complex set of risks.'
JPMorgan Chase and Morgan Stanley are collaborating to prepare the IPO of Leo Pharma in Denmark, indicating upcoming market activity.
JPMorgan Chase continues to exceed estimates on fixed income and investment banking, contributing to positive movements in the stock market.
JPMorgan posts Q1 net revenue of $49.84B, exceeding FactSet's estimate of $49.13B.
JPMorgan's Q1 net revenue was $49.84B, surpassing FactSet's estimate of $49.13B.
JPMorgan Chase and Co increased its long position in H-shares of Wuxi Apptec to 8.78% on Apr 9 from 8.23%, according to HKEX filing.
JPMorgan Chase and Co's long position in H-shares of Wuxi Apptec increases to 8.78% on Apr 9 from 8.23%, according to HKEX filing.